tradingkey.logo

Allurion Technologies Inc

ALUR

2.800USD

+0.035+1.26%
Market hours ETQuotes delayed by 15 min
16.70MMarket Cap
LossP/E TTM

Allurion Technologies Inc

2.800

+0.035+1.26%
More Details of Allurion Technologies Inc Company
Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform and health tracker devices. Its health tracker devices include Allurion Connected Scale and Allurion Health Tracker. Allurion Connected Scale offers a complete weight tracking experience, allowing users to monitor their weight, body mass index (BMI) and body composition. Allurion Health Tracker tracks steps, exercise and sleep. Allurion Virtual Care Suite is available to providers separately from the Allurion Program to help customize, monitor and manage weight-loss therapy for patients regardless of their treatment plan, which includes gastric balloon, surgical and medical or nutritional. Its Allurion Programme is offered in six months, 12 months and 12-18 months program.
Company Info
Ticker SymbolALUR
Company nameAllurion Technologies Inc
IPO dateMar 29, 2021
CEODr. Shantanu Gaur, M.D.
Number of employees134
Security typeOrdinary Share
Fiscal year-endMar 29
Address11 Huron Dr Ste 200
CityNATICK
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code01760
Phone15086474000
Websitehttps://www.allurion.com/en
Ticker SymbolALUR
IPO dateMar 29, 2021
CEODr. Shantanu Gaur, M.D.
Company Executives
Name
Name/Position
Position
Shareholding
Change
Dr. Shantanu Gaur, M.D.
Dr. Shantanu Gaur, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
78.03K
+11.42%
Ms. Milena Alberti-Perez
Ms. Milena Alberti-Perez
Independent Director
Independent Director
1.00K
--
Mr. Larson Douglas Hudson
Mr. Larson Douglas Hudson
Independent Director
Independent Director
604.00
--
Mr. Mike Cavanaugh
Mr. Mike Cavanaugh
Investor Relations
Investor Relations
--
--
Mr. Krishna K. Gupta
Mr. Krishna K. Gupta
Independent Director
Independent Director
--
--
Dr. Omar Syed Ishrak, Ph.D.
Dr. Omar Syed Ishrak, Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
--
--
Mr. Keith Johns
Mr. Keith Johns
Independent Director
Independent Director
--
--
Mr. R. Jason Richey
Mr. R. Jason Richey
Independent Director
Independent Director
--
--
Mr. Nicholas Sheridan (Nick) Lewin
Mr. Nicholas Sheridan (Nick) Lewin
Independent Director
Independent Director
--
--
Mr. Michael Davin
Mr. Michael Davin
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Shantanu Gaur, M.D.
Dr. Shantanu Gaur, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
78.03K
+11.42%
Ms. Milena Alberti-Perez
Ms. Milena Alberti-Perez
Independent Director
Independent Director
1.00K
--
Mr. Larson Douglas Hudson
Mr. Larson Douglas Hudson
Independent Director
Independent Director
604.00
--
Mr. Mike Cavanaugh
Mr. Mike Cavanaugh
Investor Relations
Investor Relations
--
--
Mr. Krishna K. Gupta
Mr. Krishna K. Gupta
Independent Director
Independent Director
--
--
Dr. Omar Syed Ishrak, Ph.D.
Dr. Omar Syed Ishrak, Ph.D.
Lead Independent Chairman of the Board
Lead Independent Chairman of the Board
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
No Data
By RegionUSD
Name
Revenue
Proportion
All other countries
4.15M
74.37%
Spain
749.00K
13.42%
Egypt (Country)
600.00K
10.75%
United Kingdom
81.00K
1.45%
France
0.00
0.00%
By Business
By Region
No Data
Shareholding Stats
Updated: Tue, Jul 29
Updated: Tue, Jul 29
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
RTW Investments L.P.
34.09%
Leavitt Equity Partners III LP
6.21%
Armistice Capital LLC
5.25%
Romulus Capital Management, LLC
2.19%
Compute Health Sponsor LLC
1.75%
Other
50.51%
Shareholders
Shareholders
Proportion
RTW Investments L.P.
34.09%
Leavitt Equity Partners III LP
6.21%
Armistice Capital LLC
5.25%
Romulus Capital Management, LLC
2.19%
Compute Health Sponsor LLC
1.75%
Other
50.51%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
35.06%
Corporation
7.96%
Hedge Fund
5.47%
Investment Advisor
3.44%
Individual Investor
2.83%
Venture Capital
2.36%
Other
42.88%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
97
4.27M
57.23%
+2.07M
2025Q1
103
2.82M
41.61%
+600.41K
2024Q4
101
1.42M
48.32%
-257.22K
2024Q3
182
1.46M
56.42%
-2.24M
2024Q2
192
1.04M
51.87%
-2.38M
2024Q1
199
922.65K
45.86%
-2.78M
2023Q4
201
923.26K
45.96%
-2.93M
2023Q3
200
857.55K
42.71%
-2.99M
2023Q2
181
182.32K
48.52%
-2.99M
2023Q1
184
191.75K
5.56%
-3.09M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
RTW Investments L.P.
2.54M
34.09%
+1.49M
+142.14%
Apr 16, 2025
Leavitt Equity Partners III LP
462.76K
6.21%
+296.10K
+177.66%
Feb 19, 2025
Armistice Capital LLC
391.64K
5.25%
+391.64K
--
Mar 31, 2025
Romulus Capital Management, LLC
163.14K
2.19%
--
--
Mar 14, 2025
Compute Health Sponsor LLC
130.51K
1.75%
-1.00
-0.00%
Mar 14, 2025
UBS Financial Services, Inc.
82.16K
1.1%
+78.69K
+2268.94%
Mar 31, 2025
Gaur (Shantanu)
78.03K
1.05%
+8.00K
+11.42%
May 19, 2025
Gupta (Krishna K.)
73.06K
0.98%
--
--
Mar 14, 2025
Olayan Investments Company Establishment
49.70K
0.67%
+2.00
+0.00%
Mar 31, 2025
The Vanguard Group, Inc.
49.37K
0.66%
+1.34K
+2.78%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
iShares Micro-Cap ETF
0%
Janus Henderson Small Cap Growth Alpha ETF
0%
iShares Micro-Cap ETF
Proportion0%
Janus Henderson Small Cap Growth Alpha ETF
Proportion0%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Dec 24, 2024
Merger
25<1
Dec 24, 2024
Merger
25<1
Dec 24, 2024
Merger
25<1
Dec 24, 2024
Merger
25<1
Date
Type
Ratio
Dec 24, 2024
Merger
25<1
Dec 24, 2024
Merger
25<1
Dec 24, 2024
Merger
25<1
Dec 24, 2024
Merger
25<1
KeyAI